ResMed Inc. (ASX:RMD)

ResMed Revenue

In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B USD with 9.84% growth. ResMed had revenue of $1.35B in the quarter ending June 30, 2025, with 10.20% growth.

• Revenue: $5.15B
• Revenue Growth: +9.84%
• P/S Ratio: 7.78
• Revenue / Employee: $485.50K
• Employees: 10,600
• Market Cap: 61.04B AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	5.15B	461.03M	9.84%
Jun 30, 2024	4.69B	462.30M	10.95%
Jun 30, 2023	4.22B	644.87M	18.02%
Jun 30, 2022	3.58B	381.30M	11.93%
Jun 30, 2021	3.20B	239.81M	8.11%
Jun 30, 2020	2.96B	350.44M	13.44%
Jun 30, 2019	2.61B	266.38M	11.38%
Jun 30, 2018	2.34B	273.46M	13.23%
Jun 30, 2017	2.07B	228.02M	12.40%
Jun 30, 2016	1.84B	159.80M	9.52%
Jun 30, 2015	1.68B	123.94M	7.97%
Jun 30, 2014	1.55B	40.52M	2.68%
Jun 30, 2013	1.51B	145.94M	10.66%
Jun 30, 2012	1.37B	125.37M	10.08%
Jun 30, 2011	1.24B	150.79M	13.80%
Jun 30, 2010	1.09B	171.62M	18.64%
Jun 30, 2009	920.74M	85.34M	10.22%
Jun 30, 2008	835.40M	119.07M	16.62%
Jun 30, 2007	716.33M	109.34M	18.01%
Jun 30, 2006	607.00M	-	-